Inventor · disambiguated record
Peng Wang
Also filed as: WANG PENG · WANG PENG GEORGE
47 granted patents·32 pending applications·296 citations·filing 1997–2025
97Inventor score
Files withJACOBIO PHARMACEUTICALS CO LTD13CRAGE MEDICAL CO LTD9ICAHN SCHOOL MED MOUNT SINAI9SUZHOU PENGXU PHARMATECH CO LTD6CAFA THERAPEUTICS LTD3
Top patents by PatentIndex Score
79 records- 0195US9382214B2Processes for the preparation of uracil derivativesCHOU HELEN·Filed 2014·Granted Jul 5, 2016·20 cites·2 claims
- 0293US11525006B2BCMA-targeting antibody and use thereofCRAGE MEDICAL CO LTD·Filed 2018·Granted Dec 13, 2022·6 cites·24 claims
- 0392US11180506B2KRAS mutant protein inhibitorsJACOBIO PHARMACEUTICALS CO LTD·Filed 2021·Granted Nov 23, 2021·3 cites·2 claims
- 0492US11111295B2Antibody for anti-claudin 18A2 and use thereofCAFA THERAPEUTICS LTD·Filed 2017·Granted Sep 7, 2021·7 cites·29 claims
- 0592US8765948B2Processes for the preparation of uracil derivativesGALLAGHER DONALD J·Filed 2008·Granted Jul 1, 2014·33 cites·5 claims
- 0692US5861279ABaculovirus expression system for human interleukin 5 receptor and method of screening for interleukin 5 antagonistsSCHERING CORP·Filed 1997·Granted Jan 19, 1999·137 cites·9 claims
- 0791US9868706B2Processes for the preparation of uracil derivativesCHOU HELEN·Filed 2017·Granted Jan 16, 2018·6 cites·2 claims
- 0890US11266647B2Method for increasing cell proliferation in pancreatic beta cells, treatment method, and compositionICAHN SCHOOL MED MOUNT SINAI·Filed 2017·Granted Mar 8, 2022·4 cites·24 claims
- 0988US9650442B2Bispecific anti-EGFR/anti IGF-1R antibodiesROCHE GLYCART AG·Filed 2014·Granted May 16, 2017·14 cites·6 claims
- 1086US10793641B2Fully human anti-mesothelin antibodies and immune effector cells targeting mesothelinCARSGEN THERAPEUTICS CO LTD·Filed 2016·Granted Oct 6, 2020·5 cites·30 claims
- 1184US11459305B2Processes for the preparation of uracil derivativesNEUROCRINE BIOSCIENCES INC·Filed 2020·Granted Oct 4, 2022·1 cites·11 claims
- 1284US11161847B2KRAS mutant protein inhibitorsJACOBIO PHARMACEUTICALS CO LTD·Filed 2021·Granted Nov 2, 2021·1 cites·2 claims
- 1384US10995099B2Compounds and their uses as ACC inhibitorsNANJING RUIJIE PHARMATECH CO LTD·Filed 2018·Granted May 4, 2021·5 cites·29 claims
- 1483US6867194B2Enzyme activated nitric oxide donorsUNIV WAYNE STATE·Filed 2001·Granted Mar 15, 2005·22 cites·20 claims
- 1582US11447570B2Binding unit targeting fibroblast activation protein α and application thereofCRAGE MEDICAL CO LTD·Filed 2018·Granted Sep 20, 2022·2 cites·12 claims
- 1682US10494347B2Processes for the preparation of uracil derivativesNEUROCRINE BIOSCIENCES INC·Filed 2017·Granted Dec 3, 2019·1 cites·8 claims
- 1777US12421232B2Kinase inhibitor compounds and compositions and methods of useICAHN SCHOOL MED MOUNT SINAI·Filed 2023·Granted Sep 23, 2025·0 cites·19 claims
- 1877US6329378B1Hydrazone, hydrazine and thiosemicarbazone derivatives as antifungal agentsANADYS PHARMACEUTICALS INC·Filed 2000·Granted Dec 11, 2001·13 cites·11 claims
- 1975US11161851B2Processes to produce acalabrutinibSUZHOU PENGXU PHARMATECH CO LTD·Filed 2018·Granted Nov 2, 2021·2 cites·23 claims
- 2074US12195473B2KRAS mutant protein inhibitorsJACOBIO PHARMACEUTICALS CO LTD·Filed 2021·Granted Jan 14, 2025·0 cites·10 claims
- 2173US11866427B2Kinase inhibitor compounds and compositions and methods of useICAHN SCHOOL MED MOUNT SINAI·Filed 2019·Granted Jan 9, 2024·1 cites·20 claims
- 2273US11788064B2Method of increasing proliferation of pancreatic beta cells, treatment method, and compositionICAHN SCHOOL MED MOUNT SINAI·Filed 2019·Granted Oct 17, 2023·1 cites·13 claims
- 2371US10221134B2Processes to produce brivaracetamESTEVE QUIM S A·Filed 2016·Granted Mar 5, 2019·2 cites·11 claims
- 2470US12364773B2Lipid nanoparticle compositions and uses thereofRECODE THERAPEUTICS INC·Filed 2024·Granted Jul 22, 2025·0 cites·39 claims
- 2570US12221413B2Processes to produce brivaracetamSUZHOU PENGXU PHARMATECH CO LTD·Filed 2019·Granted Feb 11, 2025·0 cites·9 claims
- 2670US2024269175A1Compositions and methods of cellular immunotherapyCRAGE MEDICAL CO LTD·Filed 2023·Application pending·0 cites
- 2769US11787811B2KRAS mutant protein inhibitorsJACOBIO PHARMACEUTICALS CO LTD·Filed 2021·Granted Oct 17, 2023·0 cites·15 claims
- 2869US6528644B1Acetoacetylated saccharides and process of making the sameHERCULES INC·Filed 2001·Granted Mar 4, 2003·3 cites·27 claims
- 2968US8873845B2Contextual dominant color name extractionWANG JINGDONG·Filed 2012·Granted Oct 28, 2014·2 cites·20 claims
- 3067US11596653B2Compositions and methods of cellular immunotherapyCRAGE MEDICAL CO LTD·Filed 2018·Granted Mar 7, 2023·0 cites·29 claims
- 3167US2022185880A1Antibody for anti-claudin 18a2 and use thereofCAFA THERAPEUTICS LTD·Filed 2021·Application pending·0 cites
- 3267US2024174983A1Method of increasing proliferation of pancreatic beta cells, treatment method, and compositionICAHN SCHOOL MED MOUNT SINAI·Filed 2023·Application pending·0 cites
- 3366US6846923B2Oxime-linked polysaccharides and methods of preparing the sameHERCULES INC·Filed 2001·Granted Jan 25, 2005·5 cites·40 claims
- 3466US2019218191A1Processes for the preparation of uracil derivativesNEUROCRINE BIOSCIENCES INC·Filed 2018·Application pending·0 cites
- 3564US11345701B1KRAS mutant protein inhibitorsJACOBIO PHARMACEUTICALS CO LTD·Filed 2021·Granted May 31, 2022·0 cites·10 claims
- 3661US2025121064A1Gprc5d antibody and use thereofCARSGEN LIFE SCIENCES CO LTD·Filed 2023·Application pending·0 cites
- 3760US11926633B2Synthesis methods for upadacitinib and intermediate thereofSUZHOU PENGXU PHARMATECH CO LTD·Filed 2019·Granted Mar 12, 2024·0 cites·2 claims
- 3860US2025186556A1Combination therapy with immunomodulators, dyrk1a inhibitors, and glp1r agonists for type 1 diabetes treatmentICAHN SCHOOL MED MOUNT SINAI·Filed 2023·Application pending·0 cites
- 3960US2024376128A1N-cyclopropylpyrido [4, 3-d] pyrimidin-4-amine derivatives and uses thereofJACOBIO PHARMACEUTICALS CO LTD·Filed 2022·Application pending·0 cites
- 4059US11673862B2Processes to produce brivaracetamSUZHOU PENGXU PHARMATECH CO LTD·Filed 2019·Granted Jun 13, 2023·0 cites·5 claims
- 4159US11419895B2Compositions and methods of cellular immunotherapyCRAGE MEDICAL CO LTD·Filed 2018·Granted Aug 23, 2022·0 cites·10 claims
- 4259US2025019377A11, 4-oxazepane derivatives and uses thereofJACOBIO PHARMACEUTICALS CO LTD·Filed 2022·Application pending·0 cites
- 4359US2025034166A1Polycyclic fused ring derivatives and use thereofJACOBIO PHARMACEUTICALS CO LTD·Filed 2022·Application pending·0 cites
- 4458US2025282833A1Methods for processing and analyzing virus capsid proteinsLONZA AG·Filed 2022·Application pending·0 cites
- 4557US11377426B2Processes to produce elagolixSUZHOU PENGXU PHARMATECH CO LTD·Filed 2018·Granted Jul 5, 2022·0 cites·20 claims
- 4657US2024199644A1Fused Ring Derivatives Useful as KRAS G12D InhibitorsJACOBIO PHARMACEUTICALS CO LTD·Filed 2022·Application pending·0 cites
- 4755US11884644B1Method for synthesizing (S)-nicotine and intermediate thereofSHANDONG JINCHENG PHARMACEUTICAL CHEMICAL CO LTD·Filed 2023·Granted Jan 30, 2024·0 cites·20 claims
- 4855US2025288688A1Lipid nanoparticle compositions and uses thereofRECODE THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 4955US2024025918A1KRAS G12D InhibitorsJACOBIO PHARMACEUTICALS CO LTD·Filed 2021·Application pending·0 cites
- 5055US2024059710A1KRAS G12D InhibitorsJACOBIO PHARMACEUTICALS CO LTD·Filed 2021·Application pending·0 cites
Showing the top 50 of 79 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Peng Wang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →